Clinical outcomes with paliperidone palmitate 3-monthly injection as monotherapy: observational 3-year follow-up of patients with schizophrenia.
Ivana ClarkPhoebe WallmanSiobhan Helen GeeDavid M TaylorPublished in: European psychiatry : the journal of the Association of European Psychiatrists (2024)
PP3M is a highly effective monotherapy treatment for reducing relapse in people with schizophrenia.